Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1997017445) METHOD FOR TREATING NEURODEGENERATIVE DISEASES USING A 1C2 ANTIBODY OR A FRAGMENT OR DERIVATIVE THEREOF, AND CORRESPONDING PHARMACEUTICAL COMPOSITIONS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1997/017445 International Application No.: PCT/FR1996/001773
Publication Date: 15.05.1997 International Filing Date: 08.11.1996
Chapter 2 Demand Filed: 26.05.1997
IPC:
A61K 38/00 (2006.01) ,C07K 14/47 (2006.01) ,C07K 16/18 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
46
from vertebrates
47
from mammals
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18
against material from animals or humans
Applicants:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) [FR/FR]; 3, rue Michel-Ange F-75016 Paris, FR (AllExceptUS)
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) [FR/FR]; 101, rue de Tolbiac F-75013 Paris, FR (AllExceptUS)
TORA, Lazslo [FR/FR]; FR (UsOnly)
LUTZ, Yves [FR/FR]; FR (UsOnly)
TROTTIER, Yvon [FR/FR]; FR (UsOnly)
MANDEL, Jean-Louis [FR/FR]; FR (UsOnly)
Inventors:
TORA, Lazslo; FR
LUTZ, Yves; FR
TROTTIER, Yvon; FR
MANDEL, Jean-Louis; FR
Agent:
PEAUCELLE, Chantal ; Cabinet Armengaud Ainé 3, avenue Bugeaud F-75116 Paris, FR
Priority Data:
95/1357610.11.1995FR
Title (EN) METHOD FOR TREATING NEURODEGENERATIVE DISEASES USING A 1C2 ANTIBODY OR A FRAGMENT OR DERIVATIVE THEREOF, AND CORRESPONDING PHARMACEUTICAL COMPOSITIONS
(FR) METHODE DE TRAITEMENT DE MALADIES NEURODEGENERATIVES METTANT EN OEUVRE UN ANTICORPS 1C2, UN FRAGMENT OU DERIVE DE CELUI-CI ET COMPOSITIONS PHARMACEUTIQUES CORRESPONDANTES
Abstract:
(EN) Means for treating and diagnosing neurodegenerative diseases related to the presence of polyglutamine chains by means of a 1C2 antibody are disclosed.
(FR) La présente invention concerne des moyens pour le traitement et le diagnostic des maladies neurodégénératives associées à la présence de chaînes polyglutaminiques, mettant en oeuvre un anticorps 1C2.
Designated States: CA, JP, US
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
Publication Language: French (FR)
Filing Language: French (FR)